A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia

PHASE4CompletedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions

Childhood Acute Promyelocytic Leukemia

Interventions

DRUG

ATO

Given IV

DRUG

RIF

Given orally

DRUG

ATRA

Given orally

DRUG

mitoxantrone

Given IV

DRUG

Ara-C

Given IV

DRUG

MTX

Given orally

DRUG

6MP

Given orally

OTHER

intrathecal injection

Ara-C and dexamethasone

Trial Locations (1)

The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

South China Children's Leukemia Group

OTHER

NCT02200978 - A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia | Biotech Hunter | Biotech Hunter